糖尿病性足潰瘍治療の世界市場：規模、シェア・動向分析レポート - 治療法別、潰瘍タイプ別、最終用途別、地域別、セグメント予測、2024～2030年

糖尿病性足潰瘍治療市場の成長と動向：

世界の糖尿病性足潰瘍治療の市場規模は、2024～2030年にかけてCAGR 6.0％を記録し、2030年までに77億6,000万米ドルに達すると予測されています。

糖尿病は、この地域における切断、失明、脳卒中、末期腎不全、腎不全、心臓発作の主な原因の一つです。国際糖尿病連合によると、欧州では2017年に～6,600万人が糖尿病を患っていました。この数は2045年までに8,100万人に増加すると予想されています。DFUに関連した死亡率は、最初の12ヵ月で～5％、5年後には42％まで上昇します。

非外科的デブリードマン剤、ドレッシング剤、外用剤、酸素療法、陰圧創傷治療、細胞生物製剤、ヒト成長因子、エネルギー療法、全身療法など、多くの補助療法がDFUを効果的に改善、治癒させると言われています。最近の研究では、有害なプロテイナーゼであるMMP-9酵素を阻害することで、傷の治りが早くなることが示唆されています。座りがちなライフスタイル、ヘルスケアに対するGDP支出の貧弱さ、不健康な食習慣、アジア地域における貧弱な償還シナリオが、この地域における糖尿病の高成長の要因です。それゆえ、アジア地域ではDFUの多くの弊害が観察されています。

生物製剤セグメントは2023年に最大の収益シェアを占め、予測期間中に最も高い成長率を示すと予測されています。生物製剤には、成長因子［血管内皮成長因子（VEGF）や血小板由来成長因子（PDGF）など］、幹細胞、その他の抗糖尿病薬などが含まれます。これらの薬剤は、高血糖を軽減し、酸素供給と循環を増加させ、失われた組織を修復するのに役立ちます。そのため、さまざまな段階の創傷管理に使用されることが増えており、DFU治療に理想的であると考えられています。創傷ケア用ドレッシング材は2021年に第2位の売上シェアを占め、治療用デバイスと抗生物質製剤がこれに続いた。

市場開拓企業は、DFUの治癒期間を短縮するため、常に新しく改良された製品を開発しています。ConvaTec, Inc.、Acelity L.P. Inc.、3M Healthcare、Coloplast Corp.、Smith & Nephew Plc.などの企業がこの市場をリードしています。COVID-19の発生にもかかわらず、これらの企業はCOVID-19感染に苦しむ糖尿病患者の合併症の増加により、創傷管理製品に対する需要の増加を報告しています。COVID-19治療を受けた患者が糖尿病の発症につながる糖レベルの上昇を目の当たりにしていることから、市場は2021年に安定したペースで増加すると言われています。例えば、2020年のイタリアでは、COVID-19を投与された糖尿病患者全体の割合は5％～30％でした。さらに、Smith and Nephew社は、新たに発売した創傷治癒製品PICO 7の売上が2020年に100万人を突破すると報告しました。したがって、市場は2020年に劇的に成長し、市場推計・予測期間中は安定すると予測されます。

糖尿病性足潰瘍治療の市場レポートハイライト

• 治療法別では、創傷治癒時間の短縮と血小板形成効率の向上により、生物学的製剤分野が2023年に最大の売上シェアを獲得しました。
• 潰瘍タイプ別では、神経虚血性潰瘍セグメントが2023年に圧倒的な収益シェアを占めました。
• 病院の最終用途別セグメントは、治療の採用率の上昇と経験豊富なスタッフの増加により、2023年に第2位の収益シェアを占めました。
• 北米は、市場プレイヤーの存在と治療費および償還シナリオの改善により、2023年に最大の収益シェアを獲得しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 糖尿病性足潰瘍治療市場の変数・動向

• 市場系統の見通し
• 市場力学
  • 市場促進要因の影響分析
  • 市場抑制要因の影響分析
• 業界分析ツール
  • ポーターの分析
  • マクロ経済分析
• COVID-19の影響分析
  • パンデミック後の市場洞察
• サプライチェーン分析

第4章 糖尿病性足潰瘍治療市場：治療法分析

• 治療法変動分析・市場シェア、2022～2030年
• 治療法別
• 市場規模・予測、動向分析、2018～2030年
  • 創傷ケア包帯
  • 生物製剤
  • 治療装置
  • 抗生物質薬
  • その他

第5章 糖尿病性足潰瘍治療市場：タイプ分析

• タイプ変動分析・市場シェア、2022～2030年
• タイプ別
• 市場規模・予測、動向分析、2018～2030年
  • 神経障害性潰瘍
  • 虚血性潰瘍
  • 神経虚血性潰瘍

第6章 糖尿病性足潰瘍治療市場：最終用途分析

• 最終用途変動分析・市場シェア、2022～2030年
• 最終用途別
• 市場規模・予測、動向分析、2018～2030年
  • 病院
  • 外来手術センター
  • ホームケア

第7章 糖尿病性足潰瘍治療市場：地域推定・動向分析

• 糖尿病性足潰瘍治療市場：地域別展望
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合分析

• 企業の分類
• 参加者概要
• 財務実績
• 製品のベンチマーク
• 企業の市場シェア分析、2023年
• 企業の市況分析
• 戦略マッピング
  • 合併と買収
  • 新製品の発売
  • パートナーシップとコラボレーション
  • 拡大
  • その他
• 企業プロファイル
  • ConvaTec, Group Plc
  • Acelity LP, Inc.
  • 3M Health Care
  • Coloplast Corp.
  • Smith & Nephew Plc
  • B. Braun Melsungen AG
  • Medline Industries, LP.
  • Molnlycke Health Care AB
  • Medtronic Plc

第9章 アナリストの視点

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
• Table 4. North America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 5. North America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 6. North America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 7. U.S. diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 8. U.S. diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 9. U.S. diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 10. Canada diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 11. Canada diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 12. Canada diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 13. Europe diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
• Table 14. Europe diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 15. Europe diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 16. Europe diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 17. UK diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 18. UK diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 19. UK diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 20. Germany diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 21. Germany diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 22. Germany diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 23. France diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 24. France diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 25. France diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 26. Italy diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 27. Italy diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 28. Italy diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 29. Denmark diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 30. Denmark diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 31. Denmark diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 32. Sweden diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 33. Sweden diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 34. Sweden diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 35. Norway diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 36. Norway diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 37. Norway diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 38. Asia Pacific diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
• Table 39. Asia Pacific diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 40. Asia Pacific diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 41. Asia Pacific diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 42. Japan diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 43. Japan diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 44. Japan diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 45. China diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 46. China diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 47. China diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 48. India diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 49. India diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 50. India diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 51. Australia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 52. Australia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 53. Australia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 54. South Korea diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 55. South Korea diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 56. South Korea diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 57. Thailand diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 58. Thailand diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 59. Thailand diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 60. Latin America diabetic foot ulcer market, By Country, 2018 - 2030 (USD Million)
• Table 61. Latin America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 62. Latin America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 63. Latin America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 64. Brazil diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 65. Brazil diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 66. Brazil diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 67. Mexico diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 68. Mexico diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 69. Mexico diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 70. Argentina diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 71. Argentina diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 72. Argentina diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 73. Middle East & Africa diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
• Table 74. Middle East & Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 75. Middle East & Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 76. Middle East & Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 77. South Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 78. South Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 79. South Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 80. Saudi Arabia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 81. Saudi Arabia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 82. Saudi Arabia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 83. UAE diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 84. UAE diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 85. UAE diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
• Table 86. Kuwait diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
• Table 87. Kuwait diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
• Table 88. Kuwait diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Diabetic foot ulcer treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot (Treatment & type)
• Fig. 11 Segment snapshot (End-use)
• Fig. 12 Competitive landscape
• Fig. 13 Wound care market value, 2023 (USD Billion)
• Fig. 14 Diabetic foot ulcer treatment market dynamics
• Fig. 15 Number of deaths before the age of 60 due to diabetes worldwide in 2021, by Region (in thousands)
• Fig. 16 Projections of older adult population in the U.S.: 2020 to 2060
• Fig. 17 Diabetic foot ulcer treatment market: PORTER's analysis
• Fig. 18 Diabetic foot ulcer treatment market: PESTEL analysis
• Fig. 19 Diabetic foot ulcer treatment market: by treatment: Key takeaways
• Fig. 20 Diabetic foot ulcer treatment market, by treatment: Market share, 2023 & 2030
• Fig. 21 Wound care dressings market, 2018 - 2030 (USD Million)
• Fig. 22 Alginate dressings market, 2018 - 2030 (USD Million)
• Fig. 23 Hydrofiber dressings market, 2018 - 2030 (USD Million)
• Fig. 24 Foam dressings market, 2018 - 2030 (USD Million)
• Fig. 25 Film dressing market, 2018 - 2030 (USD Million)
• Fig. 26 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
• Fig. 27 Surgical dressings market, 2018 - 2030 (USD Million)
• Fig. 28 Hydrogel dressings market, 2018 - 2030 (USD Million)
• Fig. 29 Biologics market, 2018 - 2030 (USD Million)
• Fig. 30 Growth factors market, 2018 - 2030 (USD Million)
• Fig. 31 Skin grafts market, 2018 - 2030 (USD Million)
• Fig. 32 Therapy devices market, 2018 - 2030 (USD Million)
• Fig. 33 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
• Fig. 34 Ultrasound therapy market, 2018 - 2030 (USD Million)
• Fig. 35 Antibiotic medications market, 2018 - 2030 (USD Million)
• Fig. 36 Others market, 2018 - 2030 (USD Million)
• Fig. 37 Diabetic foot ulcer treatment market: by type: Key takeaways
• Fig. 38 Diabetic foot ulcer treatment market, by type: Market share, 2023 & 2030
• Fig. 39 Neuropathic ulcers market, 2018 - 2030 (USD Million)
• Fig. 40 Ischemic ulcers market, 2018 - 2030 (USD Million)
• Fig. 41 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
• Fig. 42 Diabetic foot ulcer treatment market: by end-use: Key takeaways
• Fig. 43 Diabetic foot ulcer treatment market, by end-use: Market share, 2023 & 2030
• Fig. 44 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 45 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 46 Homecare market, 2018 - 2030 (USD Million)
• Fig. 47 Diabetic foot ulcer treatment market revenue, by region, 2023 & 2030 (USD Million)
• Fig. 48 Regional marketplace: Key takeaways
• Fig. 49 Regional marketplace: Key takeaways
• Fig. 50 North America diabetic foot ulcer treatment market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Reimbursement scenario
• Fig. 53 U.S. diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Canada diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Europe diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 UK diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Germany diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 France diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Italy diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Spain diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Sweden diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Denmark diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Norway diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Asia Pacific diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Reimbursement procurement process
• Fig. 76 Japan diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 China diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 India diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Australia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 South Korea diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Thailand diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Latin America diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Brazil diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Mexico diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Argentina diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Middle East & Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 South Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Key country dynamics
• Fig. 98 Saudi Arabia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key country dynamics
• Fig. 100 UAE diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Key country dynamics
• Fig. 102 Kuwait diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 103 Key company categorization
• Fig. 104 Company market share analysis, 2023
• Fig. 105 Company market position analysis
• Fig. 106 Strategy mapping

Diabetic Foot Ulcer Treatment Market Growth & Trends:

The global diabetic foot ulcer treatment market size is expected to reach USD 7.76 billion by 2030, registering a CAGR of 6.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Many adjuvant therapies such as nonsurgical debridement agents, dressings and topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to effectively improve and cure DFU. Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme allows the body to heal the wound at a quicker rate. Sedentary lifestyle, poor GDP expenditure on healthcare, unhealthy food habits, and poor reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region. Hence, numerous ill effects of DFU are observed in the Asian region.

The biologics segment held the largest revenue share in 2023 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the COVID-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from COVID-19 infection. The market was said to increase at a steady rate in 2021 as COVID-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with COVID-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

Diabetic Foot Ulcer Treatment Market Report Highlights:

• By treatment, the biologics segment captured the largest revenue share in 2023 owing to its reduced wound healing time and increased platelet formation efficiency
• Based on ulcer type, the neuro-ischemic ulcers segment held the dominant revenue share in 2023
• The hospitals end-use segment accounted for the second-largest revenue share in 2023 due to the increased adoption rate of treatment and highly experienced staff
• North America grabbed the largest revenue share in 2023 due to the presence of market players and improved treatment cost and reimbursement scenario

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation
• 1.2 Market Definition
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Purchased Database
  • 1.4.2 Gvr's Internal Database
  • 1.4.3 Secondary Sources
  • 1.4.4 Primary Research
• 1.5 Information Or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot (Regional)
• 2.2 Segment Snapshot (Treatment And Type)
• 2.3 Segment Snapshot (End-Use)
• 2.4 Competitive Landscape

Chapter 3 Diabetic Foot Ulcer Treatment Market Variables And Trends

• 3.1 Market Lineage Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Impact Analysis
    • 3.2.1.1 Growing Prevalence Of Diabetes
    • 3.2.1.2 Rising Geriatric Population
    • 3.2.1.3 Increasing Government Initiative
  • 3.2.2 Market Restraint Impact Analysis
    • 3.2.2.1 High Cost Of Treatment
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Analysis
  • 3.3.2 Macroeconomic Analysis
• 3.4 Covid-19 Impact Analysis
  • 3.4.1 Post-Pandemic Market Insights
• 3.5 Supply Chain Analysis

Chapter 4 Diabetic Foot Ulcer Treatment Market: Treatment Analysis

• 4.1 Treatment Movement Analysis & Market Share, 2022 & 2030
• 4.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Treatment (USD Million)
• 4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 4.3.1 Wound Care Dressings
    • 4.3.1.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.2 Alginate Dressings
    • 4.3.1.2.1 Alginate Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.3 Hydrofiber Dressings
    • 4.3.1.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.4 Foam Dressings
    • 4.3.1.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.5 Film Dressing
    • 4.3.1.5.1 Film Dressing Market, 2018 - 2030 (USD Million)
    • 4.3.1.6 Hydrocolloid Dressings
    • 4.3.1.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.7 Surgical Dressings
    • 4.3.1.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.1.8 Hydrogel Dressings
    • 4.3.1.8.1 Hydrogel Dressings Market, 2018 - 2030 (USD Million)
  • 4.3.2 Biologics
    • 4.3.2.1 Biologics Market, 2018 - 2030 (USD Million)
    • 4.3.2.2 Growth Factors
    • 4.3.2.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.3.2.3 Skin Grafts
    • 4.3.2.3.1 Skin Grafts Market, 2018 - 2030 (USD Million)
  • 4.3.3 Therapy Devices
    • 4.3.3.1 Therapy Devices Market, 2018 - 2030 (USD Million)
    • 4.3.3.2 Negative Pressure Wound Therapy
    • 4.3.3.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.3.3 Ultrasound Therapy
    • 4.3.3.3.1 Ultrasound Therapy Market, 2018 - 2030 (USD Million)
  • 4.3.4 Antibiotic Medications
    • 4.3.4.1 Antibiotic Medications Market, 2018 - 2030 (USD Million)
  • 4.3.5 Others
    • 4.3.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Diabetic Foot Ulcer Treatment Market: Type Analysis

• 5.1 Type Movement Analysis & Market Share, 2022 & 2030
• 5.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Type (USD Million)
• 5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 5.3.1 Neuropathic Ulcers
    • 5.3.1.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
  • 5.3.2 Ischemic Ulcers
    • 5.3.2.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
  • 5.3.3 Neuro-Ischemic Ulcers
    • 5.3.3.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)

Chapter 6 Diabetic Foot Ulcer Treatment Market: End-Use Analysis

• 6.1 End-Use Movement Analysis & Market Share, 2022 & 2030
• 6.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By End-Use (USD Million)
• 6.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 6.3.1 Hospitals
    • 6.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
  • 6.3.2 Ambulatory Surgical Centers
    • 6.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 6.3.3 Homecare
    • 6.3.3.1 Homecare Market, 2018 - 2030 (USD Million)

Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis

• 7.1 Diabetic Foot Ulcer Treatment Market: Regional Outlook
• 7.2 North America
  • 7.2.1 North America Diabetic Foot Ulcer Treatment Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2 U.S.
    • 7.2.2.1 Key Country Dynamics
    • 7.2.2.2 Competitive Scenario
    • 7.2.2.3 Regulatory Framework
    • 7.2.2.4 Reimbursement Scenario
    • 7.2.2.5 U.S. Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3 Canada
    • 7.2.3.1 Key Country Dynamics
    • 7.2.3.2 Competitive Scenario
    • 7.2.3.3 Regulatory Framework
    • 7.2.3.4 Reimbursement Scenario
    • 7.2.3.5 Canada Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.3 Europe
  • 7.3.1 Europe Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2 U.K
    • 7.3.2.1 Key Country Dynamics
    • 7.3.2.2 Competitive Scenario
    • 7.3.2.3 Regulatory Framework
    • 7.3.2.4 Reimbursement Scenario
    • 7.3.2.5 U.K Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3 Germany
    • 7.3.3.1 Key Country Dynamics
    • 7.3.3.2 Competitive Scenario
    • 7.3.3.3 Regulatory Framework
    • 7.3.3.4 Reimbursement Scenario
    • 7.3.3.5 Germany Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4 France
    • 7.3.4.1 Key Country Dynamics
    • 7.3.4.2 Competitive Scenario
    • 7.3.4.3 Regulatory Framework
    • 7.3.4.4 Reimbursement Scenario
    • 7.3.4.5 France Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5 Italy
    • 7.3.5.1 Key Country Dynamics
    • 7.3.5.2 Competitive Scenario
    • 7.3.5.3 Regulatory Framework
    • 7.3.5.4 Reimbursement Scenario
    • 7.3.5.5 Italy Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6 Spain
    • 7.3.6.1 Key Country Dynamics
    • 7.3.6.2 Competitive Scenario
    • 7.3.6.3 Regulatory Framework
    • 7.3.6.4 Reimbursement Scenario
    • 7.3.6.5 Spain Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.7 Sweden
    • 7.3.7.1 Key Country Dynamics
    • 7.3.7.2 Competitive Scenario
    • 7.3.7.3 Regulatory Framework
    • 7.3.7.4 Reimbursement Scenario
    • 7.3.7.5 Sweden Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8 Denmark
    • 7.3.8.1 Key Country Dynamics
    • 7.3.8.2 Competitive Scenario
    • 7.3.8.3 Regulatory Framework
    • 7.3.8.4 Reimbursement Scenario
    • 7.3.8.5 Denmark Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.9 Norway
    • 7.3.9.1 Key Country Dynamics
    • 7.3.9.2 Competitive Scenario
    • 7.3.9.3 Regulatory Framework
    • 7.3.9.4 Reimbursement Scenario
    • 7.3.9.5 Norway Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2 Japan
    • 7.4.2.1 Key Country Dynamics
    • 7.4.2.2 Competitive Scenario
    • 7.4.2.3 Regulatory Framework
    • 7.4.2.4 Reimbursement Scenario
    • 7.4.2.5 Japan Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3 China
    • 7.4.3.1 Key Country Dynamics
    • 7.4.3.2 Competitive Scenario
    • 7.4.3.3 Regulatory Framework
    • 7.4.3.4 Reimbursement Scenario
    • 7.4.3.5 China Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4 India
    • 7.4.4.1 Key Country Dynamics
    • 7.4.4.2 Competitive Scenario
    • 7.4.4.3 Regulatory Framework
    • 7.4.4.4 Reimbursement Scenario
    • 7.4.4.5 India Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5 Australia
    • 7.4.5.1 Key Country Dynamics
    • 7.4.5.2 Competitive Scenario
    • 7.4.5.3 Regulatory Framework
    • 7.4.5.4 Reimbursement Scenario
    • 7.4.5.5 Australia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6 South Korea
    • 7.4.6.1 Key Country Dynamics
    • 7.4.6.2 Competitive Scenario
    • 7.4.6.3 Regulatory Framework
    • 7.4.6.4 Reimbursement Scenario
    • 7.4.6.5 South Korea Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7 Thailand
    • 7.4.7.1 Key Country Dynamics
    • 7.4.7.2 Competitive Scenario
    • 7.4.7.3 Regulatory Framework
    • 7.4.7.4 Reimbursement Scenario
    • 7.4.7.5 Thailand Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5 Latin America
  • 7.5.1 Latin America Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2 Brazil
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement Scenario
    • 7.5.2.5 Brazil Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3 Mexico
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement Scenario
    • 7.5.3.5 Mexico Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4 Argentina
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement Scenario
    • 7.5.4.5 Argentina Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6 Middle East & Africa
  • 7.6.1 Middle East & Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2 South Africa
    • 7.6.2.1 Key Country Dynamics
    • 7.6.2.2 Competitive Scenario
    • 7.6.2.3 Regulatory Framework
    • 7.6.2.4 Reimbursement Scenario
    • 7.6.2.5 South Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3 Saudi Arabia
    • 7.6.3.1 Key Country Dynamics
    • 7.6.3.2 Competitive Scenario
    • 7.6.3.3 Regulatory Framework
    • 7.6.3.4 Reimbursement Scenario
    • 7.6.3.5 Saudi Arabia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4 UAE
    • 7.6.4.1 Key Country Dynamics
    • 7.6.4.2 Competitive Scenario
    • 7.6.4.3 Regulatory Framework
    • 7.6.4.4 Reimbursement Scenario
    • 7.6.4.5 UAE Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5 Kuwait
    • 7.6.5.1 Key Country Dynamics
    • 7.6.5.2 Competitive Scenario
    • 7.6.5.3 Regulatory Framework
    • 7.6.5.4 Reimbursement Scenario
    • 7.6.5.5 Kuwait Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis

• 8.1 Company Categorization
• 8.2 Participants' Overview
• 8.3 Financial Performance
• 8.4 Product Benchmarking
• 8.5 Company Market Share Analysis, 2023
• 8.6 Company Market Position Analysis
• 8.7 Strategy Mapping
  • 8.7.1 Mergers & Acquisitions
  • 8.7.2 New Product Launch
  • 8.7.3 Partnerships & Collaborations
  • 8.7.4 Expansion
  • 8.7.5 Others
• 8.8 Company Profiles
  • 8.8.1 ConvaTec, Group Plc
    • 8.8.1.1 Company overview
    • 8.8.1.2 Finacial performance
    • 8.8.1.3 Product benchmarking
    • 8.8.1.4 Strategic initiatives
  • 8.8.2 Acelity L.P., Inc.
    • 8.8.2.1 Company overview
    • 8.8.2.2 Finacial performance
    • 8.8.2.3 Product benchmarking
    • 8.8.2.4 Strategic initiatives
  • 8.8.3 3M Health Care
    • 8.8.3.1 Company overview
    • 8.8.3.2 Finacial performance
    • 8.8.3.3 Product benchmarking
    • 8.8.3.4 Strategic initiatives
  • 8.8.4 Coloplast Corp.
    • 8.8.4.1 Company overview
    • 8.8.4.2 Finacial performance
    • 8.8.4.3 Product benchmarking
    • 8.8.4.4 Strategic initiatives
  • 8.8.5 Smith & Nephew Plc
    • 8.8.5.1 Company overview
    • 8.8.5.2 Finacial performance
    • 8.8.5.3 Product benchmarking
    • 8.8.5.4 Strategic initiatives
  • 8.8.6 B. Braun Melsungen AG
    • 8.8.6.1 Company overview
    • 8.8.6.2 Finacial performance
    • 8.8.6.3 Product benchmarking
    • 8.8.6.4 Strategic initiatives
  • 8.8.7 Medline Industries, LP.
    • 8.8.7.1 Company overview
    • 8.8.7.2 Finacial performance
    • 8.8.7.3 Product benchmarking
    • 8.8.7.4 Strategic initiatives
  • 8.8.8 Molnlycke Health Care AB
    • 8.8.8.1 Company overview
    • 8.8.8.2 Finacial performance
    • 8.8.8.3 Product benchmarking
    • 8.8.8.4 Strategic initiatives
  • 8.8.9 Medtronic Plc
    • 8.8.9.1 Company overview
    • 8.8.9.2 Finacial performance
    • 8.8.9.3 Product benchmarking
    • 8.8.9.4 Strategic initiatives

Chapter 9 Analyst Perspective